AUS
NZ
UK
CA
USA
IND
ALS Limited (ASX:ALQ), a global leader in testing, inspection and certification (TIC) services, announced a record financial outcome for the 2026 fiscal year during its Annual General Meeting. The company posted an underlying net profit after tax of $381.2 million, achieving its five-year strategic financial target a year ahead of schedule. ALS's diverse testing portfolio across minerals, environmental, food, pharmaceutical, and industrial materials sectors showed resilience amid geopolitical challenges, with revenues rising 10.7% and underlying EBIT margin increasing by 129 basis points to 18.0%. This robust performance enabled a 10.3% increase in total dividends to 42.5 cents per share.
Key Highlights
- ALS Limited (ALQ) is a diversified international TIC company with strong market positions in minerals, environmental, food, pharma, and industrial materials testing across multiple regions.
- In FY26, ALS achieved a record underlying net profit after tax of $381.2 million, marking a 25.8% increase year-over-year despite geopolitical uncertainties.
- The company reached its FY27 five-year strategic financial goal one year early, with revenue growth of 10.7%, an underlying EBIT margin of 18.0% (up 129 basis points), and dividends of 42.5 cents per share (up 10.3%).
- Capital management highlights include $263 million in gross capital expenditure excluding acquisitions, leverage ratio improvement from 2.3x to 1.5x, and $93.7 million invested in four major hub laboratory expansion projects slated for FY27 commissioning.
- Investors should watch for the commissioning of Sydney and Lima facilities in FY27, the ongoing board replacement search, and execution of ALS’s Roadmap to Win strategy capitalizing on structural industry megatrends.
FY26 Record Net Profit Fueled by Commodity Sector Strength and Operational Leverage
ALS Limited recorded its highest-ever underlying net profit after tax of $381.2 million in FY26, reflecting a 25.8% year-on-year increase. This outstanding result was driven by strong operational performance across ALS’s diversified business units, particularly those linked to commodity markets. The company highlighted that favorable trading conditions in commodity-exposed segments significantly contributed to this outcome, underscoring the advantage of its broad geographic and market exposure.
Alongside profit growth, ALS achieved a 10.7% increase in revenue, demonstrating sustained global demand for its testing and certification services. The underlying EBIT margin expanded by 129 basis points to 18.0%, signaling enhanced operating leverage and favorable trading environments. This margin improvement illustrates ALS’s capacity to convert revenue gains into profit growth through disciplined cost control and operational efficiency. Achieving record profitability while maintaining strong margin discipline highlights ALS’s effective capital allocation and operational execution amid mixed global market conditions.
Accelerated Achievement of Five-Year Strategic Financial Target Highlights Strong Execution
A key highlight of ALS’s FY26 results was surpassing its FY27 five-year strategic financial target one year early. This milestone reflects the company’s accelerated growth strategy and efficient capital deployment. The early attainment was driven by record profitability, solid revenue growth, and margin expansion, supported by the resilience of ALS’s diversified portfolio.
Operating within a global TIC industry benefiting from long-term structural trends—such as increasing outsourced testing, stricter regulatory standards, critical minerals demand, energy transition, and resource nationalism—ALS is well positioned to capitalize on sustained demand for independent, high-quality testing services across mining, environmental compliance, food safety, and pharmaceutical sectors. Achieving this target early strengthens ALS’s financial flexibility to pursue further growth opportunities aligned with these industry megatrends.
Hub Laboratory Expansion Program on Track with $93.7 Million Invested in FY26
In FY26, ALS invested $93.7 million in four major hub laboratory projects announced during its June 2025 capital raising. These investments aim to expand ALS’s global platform in minerals and environmental testing markets. The hub lab expansion enhances ALS’s laboratory network in key regions where it holds leading market shares, while improving operational efficiency through smart automation and modern facility designs.
All four hub labs remain on schedule and within budget, reflecting strong capital discipline and project management. ALS expects to commission the Sydney and Lima facilities in FY27, which will add capacity to support both short- and long-term growth initiatives. These strategically located labs are poised to capture incremental market share and boost revenue growth in minerals and environmental testing segments, benefiting from the TIC industry’s structural megatrends.
Capital Discipline and Leverage Reduction Support Growth Ambitions
ALS maintained disciplined capital management in FY26, with gross capital expenditure excluding acquisitions totaling $263 million. Net cash spent on mergers and acquisitions was $9.8 million, primarily related to deferred payments for prior deals. The company’s leverage ratio improved significantly from 2.3x to 1.5x, falling below its internal target range of 1.7x to 2.3x. This reflects strong cash flow generation and prudent capital deployment.
The Board prioritizes capital allocation to opportunities delivering at least a 15% return on capital employed, consistent with ALS’s Value Creation Framework. With leverage below 1.7x, ALS has substantial financial flexibility to invest organically in capacity and technology or pursue selective acquisitions. This financial strength enables counter-cyclical investments and strategic acquisitions that enhance ALS’s competitive positioning amid evolving industry dynamics.
Dividend Raised to 42.5 Cents Per Share Demonstrating Commitment to Shareholders
Supported by strong financial results, ALS increased its total FY26 dividend to 42.5 cents per share, a 10.3% rise over the previous year. The final dividend increase and a 57% payout ratio align with the company’s updated dividend policy, balancing shareholder returns with reinvestment for growth.
This dividend increase reflects management and Board confidence in ALS’s sustainable earnings and cash flow. The payout ratio balances maximizing shareholder returns with maintaining financial flexibility for capital investments and debt management. Given favorable industry tailwinds and ALS’s market leadership, the dividend policy underscores a commitment to progressive returns while preserving capital deployment optionality aligned with the company’s 15% return on capital employed threshold.
Remuneration Framework Updated Following Strong Performance and Shareholder Input
In FY26, fixed remuneration for Key Management Personnel (KMP) increased between 0% and 3.5%, reflecting performance and market factors. Short-term incentives for KMP ranged from 95% to 97% of maximum, aligned with shareholder value delivered. Long-term incentive (LTI) awards vested at 72.1%, with full vesting on EBITDA and total shareholder return hurdles, partial vesting on return on capital employed, and no vesting on earnings per share targets.
Responding to shareholder feedback, the Board approved FY27 remuneration changes, including raising the LTI return on capital employed target by one percentage point to 16.5%-21.5%, reflecting improved capital efficiency. Base salaries for the CEO and CFO will increase by 5%, and the CEO’s LTI opportunity will rise from 150% to 180%. These adjustments demonstrate confidence in executive leadership and commitment to retaining talent to execute ALS’s growth strategy.
Board Transition with John Mulcahy’s Retirement and Successor Search
John Mulcahy will retire from the ALS Board at the close of the 2026 Annual General Meeting after 14 years of service. The company recognized his significant contributions as a Committee Chair and member, noting his valuable and thoughtful counsel. This marks an important governance transition that ALS is managing proactively.
ALS is nearing completion of its search for a replacement director, with an announcement expected soon. Despite Mulcahy’s departure, the Board maintains a diverse mix of tenure, skills, and experience to continue serving shareholders effectively. The timing and approach to board renewal prioritize continuity and retention of institutional knowledge while integrating fresh perspectives suited to the complexities of a global TIC enterprise.
Strategic Positioning Leveraging Global TIC Market and Industry Megatrends
ALS is a specialized global TIC leader with a diversified service portfolio and strong market positions. Its business model features leadership in minerals and environmental testing supported by flexible hub-and-spoke operations that drive market share and margins, alongside well-established regional portfolios in food, pharma, and industrial materials testing. This diversification provides earnings stability and multiple growth avenues aligned with structural industry trends.
The company identified key megatrends fueling long-term demand: increasing outsourced testing, tighter regulations, critical minerals demand, energy transition, and resource nationalism. These factors sustain demand for independent, high-quality testing across vital sectors. ALS’s Roadmap to Win strategy aims to capitalize on these trends through its differentiated portfolio and operating model, targeting sustainable above-market growth. The company’s AI-first approach, embedding artificial intelligence in new solutions from inception, reflects its commitment to leveraging technology to enhance service quality and operational efficiency.
Culture of Innovation and Data-Driven Strategy Driving Sustainable Growth
ALS emphasized a strong culture of curiosity and innovation supported by a data-driven approach as key enablers of sustainable growth. This foundation supports executing the growth strategy and capturing opportunities from industry megatrends. Strategic investments in hub labs with smart automation and modern designs enhance capacity and efficiency.
Integrating data-driven decision-making with innovation enables ALS to identify and pursue emerging TIC market opportunities stemming from regulatory changes, technological advancements, and evolving customer needs. This approach is critical given exposure to dynamic sectors like energy transition and critical minerals. ALS’s track record of record profits, margin expansion, and substantial growth investments validates the effectiveness of its cultural and strategic approach.
